Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCPL
1626
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $14M | 0.01% |
677,413
+610,739
| +916% | +$10.8M |
|
1627
PUT
Air Products & Chemicals
APD
$67.7B
| $14M | 0.01% |
54,700
-5,900
| -10% | -$1.63M |
|
1628
PUT
State Street SPDR S&P Retail ETF
XRT
$325M
| $14M | 0.01% |
154,900
+105,000
| +210% | +$9.97M |
|
1629
Brighthouse Financial
BHF
$2.98B
| $14M | 0.01% |
309,301
+54,736
| +22% | +$2.47M |
|
|
ESM.U
1630
DELISTED
ESM Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ESM.U
| $14M | 0.01% |
1,407,716
-195,800
| -12% | -$1.95M |
|
1631
Columbia Sportswear
COLM
$3.02B
| $14M | 0.01% |
145,758
+19,376
| +15% | +$1.96M |
|
1632
Kite Realty
KRG
$5.3B
| $14M | 0.01% |
685,991
+389,939
| +132% | +$7.91M |
|
|
CRZN
1633
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
| $13.9M | 0.01% |
1,432,593
+722,600
| +102% | +$7.01M |
|
1634
Old National Bancorp
ONB
$9.82B
| $13.9M | 0.01% |
820,738
+257,886
| +46% | +$4.25M |
|
1635
Diodes
DIOD
$4.28B
| $13.9M | 0.01% |
153,523
-243,426
| -61% | -$21.3M |
|
1636
Eastern Bankshares
EBC
$5.11B
| $13.9M | 0.01% |
684,664
+100,654
| +17% | +$1.93M |
|
1637
Principal Financial Group
PFG
$23.9B
| $13.9M | 0.01% |
215,700
-431,119
| -67% | -$27.7M |
|
1638
Lennar Class A
LEN
$21.1B
| $13.9M | 0.01% |
153,108
+100,729
| +192% | +$9.97M |
|
|
VRAY
1639
DELISTED
ViewRay, Inc.
VRAY
| $13.9M | 0.01% |
1,924,370
+872,165
| +83% | +$5.51M |
|
1640
XP
XP
$9.03B
| $13.9M | 0.01% |
344,988
+106,447
| +45% | +$4.75M |
|
1641
Ashland
ASH
$3.38B
| $13.9M | 0.01% |
155,492
+30,147
| +24% | +$2.65M |
|
1642
Trade Desk
TTD
$6.23B
| $13.9M | 0.01% |
197,098
+153,843
| +356% | +$11.9M |
|
|
EA
1643
CALL
DELISTED
Electronic Arts
EA
| $13.9M | 0.01% |
97,400
-83,600
| -46% | -$11.7M |
|
1644
PUT
AstraZeneca
AZN
$263B
| $13.8M | 0.01% |
257,700
+206,550
| +404% | +$24M |
|
1645
P3 Health Partners
PIII
$40.3M
| $13.8M | 0.01% |
28,080
+12,796
| +84% | +$6.31M |
|
1646
PUT
Macy's
M
$5.94B
| $13.8M | 0.01% |
612,400
-3,500
| -0.6% | -$70K |
|
1647
Welltower
WELL
$174B
| $13.8M | 0.01% |
167,941
+98,202
| +141% | +$8.44M |
|
1648
CALL
Dell
DELL
$292B
| $13.8M | 0.01% |
262,409
+60,176
| +30% | +$3M |
|
1649
Mohawk Industries
MHK
$9.06B
| $13.8M | 0.01% |
77,900
-333,293
| -81% | -$64.6M |
|
1650
PUT
HCA Healthcare
HCA
$92.8B
| $13.8M | 0.01% |
56,900
-8,600
| -13% | -$2.1M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.